Wednesday, April 08, 2009

Medicine ...


Per FDA update,
(URL: http://www.fda.gov/medwatch/safety/2009/safety09.htm#Raptiva )

"Genentech and FDA notified healthcare professionals of the voluntary, phased withdrawal of Raptiva, a medication for treatment of psoriasis, from the U.S. market due to a potential risk to patients of developing progressive multifocal leukoencephalopathy (PML). "

Drug and more drug...
Soon, we may lose track of what drug interacts with which drug.

[][][]

0 Comments:

Post a Comment

<< Home